Unknown

Dataset Information

0

Molecular Dynamics Simulation of Atomic Interactions in the Vancomycin Binding Site.


ABSTRACT: Vancomycin is a glycopeptide antibiotic produced by Amycolaptopsis orientalis used to treat serious infections by Gram-positive pathogens including methicillin-resistant Staphylococcus aureus. Vancomycin inhibits cell wall biosynthesis by targeting lipid II, which is the membrane-bound peptidoglycan precursor. The heptapeptide aglycon structure of vancomycin binds to the d-Ala-d-Ala of the pentapeptide stem structure in lipid II. The third residue of vancomycin aglycon is asparagine, which is not directly involved in the dipeptide binding. Nonetheless, asparagine plays a crucial role in substrate recognition, as the vancomycin analogue with asparagine substituted by aspartic acid (VD) shows a reduction in antibacterial activities. To characterize the function of asparagine, binding of vancomycin and its aspartic-acid-substituted analogue VD to l-Lys-d-Ala-d-Ala and l-Lys-d-Ala-d-Lac was investigated using molecular dynamic simulations. Binding interactions were analyzed using root-mean-square deviation (RMSD), two-dimensional (2D) contour plots, hydrogen bond analysis, and free energy calculations of the complexes. The analysis shows that the aspartate substitution introduced a negative charge to the binding cleft of VD, which altered the aglycon conformation that minimized the repulsive lone pair interaction in the binding of a depsipeptide. Our findings provide new insight for the development of novel glycopeptide antibiotics against the emerging vancomycin-resistant pathogens by chemical modification at the third residue in vancomycin to improve its binding affinity to the d-Ala-d-Lac-terminated peptidoglycan in lipid II found in vancomycin-resistant enterococci and vancomycin-resistant S. aureus.

SUBMITTER: Olademehin OP 

PROVIDER: S-EPMC7808135 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular Dynamics Simulation of Atomic Interactions in the Vancomycin Binding Site.

Olademehin Olatunde P OP   Kim Sung Joon SJ   Shuford Kevin L KL  

ACS omega 20201222 1


Vancomycin is a glycopeptide antibiotic produced by <i>Amycolaptopsis orientalis</i> used to treat serious infections by Gram-positive pathogens including methicillin-resistant <i>Staphylococcus aureus</i>. Vancomycin inhibits cell wall biosynthesis by targeting lipid II, which is the membrane-bound peptidoglycan precursor. The heptapeptide aglycon structure of vancomycin binds to the d-Ala-d-Ala of the pentapeptide stem structure in lipid II. The third residue of vancomycin aglycon is asparagin  ...[more]

Similar Datasets

| S-EPMC3221501 | biostudies-literature
| S-EPMC11776045 | biostudies-literature
| S-EPMC3749139 | biostudies-literature
| S-EPMC4407268 | biostudies-literature
| S-EPMC5422863 | biostudies-literature
| S-EPMC5500594 | biostudies-literature
| S-EPMC6305025 | biostudies-literature
| S-EPMC6686837 | biostudies-literature
| S-EPMC3825559 | biostudies-literature
| S-EPMC3706581 | biostudies-literature